Adult High Risk Vaccine Initiative
Adult High Risk Vaccine Initiative (AHB)
The purpose of the Adult High Risk Vaccine Initiative (AHB) is to improve the delivery of viral hepatitis prevention services in health-care settings and public health programs that serve adults at risk for viral hepatitis. The primary goals are:
Increase
the number of doses of hepatitis B-containing vaccine purchased by immunization program grantees;Reduce
the incidence of acute hepatitis B among adults in the United States; andImprove
overall vaccination coverage among adults.AHB vaccines under this Initiative are available only to people who meet the following conditions:
- Individuals who are 19 years of age and older; and
- who have no insurance.
a. COVID-19 vaccines may be available for under-insured individuals who seek vaccination at select Federally Qualified Health Centers (FQHC)/Rural Health Centers (RHC) locations or their Local Health Department.
Vaccines are free, but there may be an administration fee charged to give the vaccines. The maximum fee is $20.72 per dose.
Available vaccines include:
- Adacel (Tdap)
- Havrix (Hepatitis A)
- Heplisav-B (Hepatitis B)
- Gardasil (HPV)
- Prevnar20 (PCV)
- Shingrix (Zoster)
- Spikevax (COVID-19)
- Novavax (COVID-19)